Skip to main content
SpringerLink
Log in

Combined Modality Therapy of Gastrointestinal Tract Cancer

  • Conference proceedings
  • © 1988

Overview

Editors:
  1. Peter Schlag

    1. Chirurgische Klinik, Klinikum der Universität Heidelberg, Heidelberg, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Peter Hohenberger

    1. Chirurgische Klinik, Klinikum der Universität Heidelberg, Heidelberg, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Urs Metzger

    1. Departement Chirurgie, Universitätsspital Zürich, Zürich, Switzerland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 110)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (40 papers)

  1. Combined Therapy in Anal Carcinoma

    1. Preoperative Radio-Chemotherapy in Anal Carcinoma

      • H. Denecke, R. Roloff
      Pages 134-139

    2. Combined Modality Treatment of Anal Carcinoma

      • W. Dobrowsky, E. Dobrowsky
      Pages 140-145

    3. Current Therapeutic Concepts in Management of Carcinoma of the Anal Canal

      • J. Papillon
      Pages 146-149

  2. Treatment of Liver Metastases of Colorectal Cancer

    1. Approach of the Treatment of Colorectal Liver Metastases

      • A. Flowerdew, I. Taylor
      Pages 150-163

    2. Patterns of Failure Following Surgical Resection of Colorectal Cancer Liver Metastases: Rationale for a Multimodal Approach

      • F. Bozzetti, R. Doci, P. Bignami, A. Morabito, L. Gennari
      Pages 164-167

    3. Regional Chemotherapy of the Liver for Colorectal Malignancies

      • H. H. Gruenagel, E. Molzahn, U. Freund, D. Groß
      Pages 168-174

    4. Interim Results of Intra-Arterial 4’-Epi-Doxorubicin for Liver Metastases

      • G. Simoni, M. T. Nobile, M. Repetto, P. L. Percivale, S. Razzi, R. Tatarek et al.
      Pages 175-177

    5. The Use of an Implantable Vascular Occluder in the Treatment of Nonresectable Hepatic Malignancies

      • B. Persson, B. Jeppsson, M. C. A. Puntis, H. Ekberg, K. Tranberg, S. Bengmark
      Pages 178-180

    6. Hepatic Arterial Ligation with and Without Portal Infusion in Metastatic Colorectal Cancer

      • A. Gerard, O. Dalesio, N. Duez, H. Bleiberg, J. C. Pector, M. Lise et al.
      Pages 181-186

    7. Basic Investigations on Interaction of 5-Fluorouracil and Tumor Ischemia in the Treatment of Liver Malignancies

      • B. Eibl-Eibesfeldt, V. Storz, J. Kummermehr, A. Schalhorn
      Pages 187-195

  3. Current Chemotherapeutic Trials in GI-Tract Cancer

    1. Systemic Chemotherapy with Cisplatin, 5-Fluorouracil and Allopurinol in the Management of Advanced Epidermoid Esophageal Cancer

      • P. De Besi, V. Chiarion-Sileni, L. Salvagno, S. Toso, A. Paccagnella, V. Fosser et al.
      Pages 196-197

    2. Phase-II-Study with EAP (Etoposide, Adriamycin, Cis- Platinum) in Patients with Primary Inoperable Gastric Cancer and Advanced Disease

      • P. Preusser, H. Wilke, W. Achterrath, U. Fink, P. Neuhaus, J. Meyer et al.
      Pages 198-206

    3. Background for and Progress of an Ongoing EORTC Phase-II Study in Metastatic Gastric Cancer

      • G. H. Blijham
      Pages 207-211

    4. 5-Fluorouracil Versus a Combination of BCNU, Adriamycin, 5- FU and Mitomycin C in Advanced Gastric Cancer: A Prospective Randomized Study of the Italian Clinical Research Oncology Group

      • V. De Lisi, G. Cocconi, M. Tonato, F. Di Costanzo, F. Leonardi, M. Soldani
      Pages 212-218

    5. 5-Methyltetrahydrofolic Acid (MFH4): An Effective Folate for the Treatment of Advanced Colorectal Cancer with 5-FU

      • P. La Ciura, G. La Grotta, E. Nigra, A. Comandone, G. Grecchi, G. Leria et al.
      Pages 219-225

  4. New Therapeutic Approaches to GI-Tract Cancer

    1. Intraoperative Radiotherapy in Carcinoma of the Stomach and Pancreas

      • W. F. Sindelar
      Pages 226-243

    2. Is There a Role for Hyperthermia in Gastrointestinal Tract Cancer?

      • J. Overgaard, M. Overgaard
      Pages 244-253

    3. Intraperitoneal Chemotherapy and Immunotherapy

      • B. E. Wolf, P. H. Sugarbaker
      Pages 254-273

    4. Predictive Assays for the Therapy of Rectal Carcinoma

      • C. Streffer, D. van Beuningen, M.-L. Mlynek, E. Gross, F.-W. Eigler
      Pages 274-280

    5. Therapy of Carcinoid Tumors with [131I] Meta-Iodo-Benzyl-Guanidine

      • J. Adolph, B. Kimmig, M. Eisenhut, P. Georgi
      Pages 281-285
Back to top

Keywords

About this book

Modern surgical oncology is characterized by multimodal therapy. In recent years numerous therapeutic approaches of pre-, peri-, intra-and postoperative treatment have been in­ vestigated with regard to their use in combination with surgi­ cal intervention. It now is time to analyze and to define the state of our knowledge. For tumors of the gastrointestinal tract there are several encouraging therapeutic approaches, such as preop­ erative chemotherapy in esophageal and perioperative chemotherapy in colon cancer. For some special tumors, like anal carcinoma, we have clearly defined combined therapies which even now must be viewed as standard treatment. It is also time to demonstrate the results of several clini­ cal studies that have been conducted within the last few years that combined surgical efforts with pre- or postinter­ ventional chemotherapy or radiotherapy. It is necessary to evaluate whether these trials contribute to progress in onco­ logical therapy. The editors of this volume - surgeons at the university hospitals of Heidelberg and Zurich - must be given the mer­ it of achieving these goals. It was especially appropriate for the Department of Surgery in Heidelberg, in close coopera­ tion with the Comprehensive Cancer Center Heidelberg/ Mannheim, to prepare a review of our present knowledge of surgical oncology as it is in the tradition of attempting to combine different therapeutic approaches to cancer therapy.

Editors and Affiliations

  • Chirurgische Klinik, Klinikum der Universität Heidelberg, Heidelberg, Germany

    Peter Schlag, Peter Hohenberger

  • Departement Chirurgie, Universitätsspital Zürich, Zürich, Switzerland

    Urs Metzger

Bibliographic Information

  • Book Title: Combined Modality Therapy of Gastrointestinal Tract Cancer

  • Editors: Peter Schlag, Peter Hohenberger, Urs Metzger

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-83293-2

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1988

  • Softcover ISBN: 978-3-642-83295-6Published: 19 January 2012

  • eBook ISBN: 978-3-642-83293-2Published: 06 December 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XVII, 301

  • Topics: Oncology, Hepatology, Gastroenterology, Abdominal Surgery

Publish with us

Policies and ethics

Back to top

Search

Navigation